Lumito launches new image visualisation and analysis software in partnership with Katana Labs
We are excited to announce that the partnership between Lumito and Katana Labs has resulted in a customised analysis software solution tailored specifically for Lumito’s customers. Lumito and Katana Labs are launching an innovative, cloud-based image analysis and visualisation software. The new solution is specifically optimised for Lumito’s unique Scizys tissue imaging technology, which combines […]
Lumito and Concept Life Sciences join forces to advance tissue analysis in drug discovery
We are excited to announce a collaboration between Lumito and Concept Life Sciences, a CRO (contract research organisation) based in UK, to enhance tissue analysis in drug discovery and development. This joint project will focus on evaluating and optimising Lumito’s innovative product Scizys, within Concept Life Sciences’ cutting-edge research service. This collaboration is more than […]
Lumito AB publishes year-end report 2024
Financial Overview Fourth quarter 2024, October 1 to December 31• Net sales amounted to TSEK 79 (0).• Result after taxes amounted to TSEK-15,476 (-5,777).• Earnings per share before and after dilution amounted to SEK -0.06 (-0.03).• Cash flow from operating activities after changes in working capital amounted to TSEK -6,213 (-5,480). Full Year 2024, 1 […]
Lumito and Truly Labs join forces to drive innovation and enhanced competitiveness in tissue analysis
We are excited to announce that Lumito and Truly Labs are joining forces in a strategic partnership to develop innovative, value-driven solutions that provide both companies with a competitive edge in tissue analysis. “We are truly happy about this partnership where we will work together to improve the quality and objectivity of tissue analysis. Combining […]
Lumito focus on the accelerated commercialisation of SCIZYS and are initiating a cost-reduction programme
Lumitos focus is commercialisation of SCIZYS and to ensure market introduction. The company will enter into a new loan agreement of 12,5 MSEK, which was announced in a separate press release, and at the same time initiate a cost reduction program. The cost savings are calculated to be 14 MSEK at a minimum annually and […]
Lumito refinances loan of SEK 12.5 million
The board of directors of Lumito AB ("Lumito" or the "Company") has decided to refinance parts of existing loan of SEK 20 million excluding interest from Fenja Capital II A/S (the “Existing Loan”) through a new loan of SEK 12.5 million (the “Loan”) from Fenja Capital II A/S (formerly Formue Nord Fokus A/S, the “Lender”). […]
Warrants of series TO6 were subscribed to approximately 94 percent and Lumito receives approximately SEK 12.6 million
Lumito AB (publ) ("Lumito" or the "Company") today announces the outcome of the exercise of warrants of series TO6, which were issued in connection to an issue and loan financing during the fourth quarter of 2023. In total, 32,206,770 warrants were exercised, corresponding to approximately 94 percent of the total number of outstanding warrants, for […]
Members of Lumitos board and management team intend to exercise warrants of series TO6
Members of the board and management that hold warrants of series TO6 Lumito AB (publ) ("Lumito" or the "Company") intend to exercise 575,512 warrants to a value of SEK 224 thousand. The board and management team intends to exercise warrants, directly or via companies, according to the following: Kerstin Jakobsson (Chair of the Board) – […]
The last day of trading with the warrants of series TO6 in Lumito AB is today, November 12, 2024
Today, November 12, 2024, is the last day of trading with the warrants of series TO6 in Lumito AB (publ) (“Lumito” or the “Company”). The exercise period for the warrants runs up to and including November 15, 2024. Each warrant of series TO6 gives the owner the right to subscribe for one (1) new share […]
The subscription price for exercise of warrants of series TO6 in Lumito AB is set to SEK 0.39 and the subscription period commences today November 4, 2024
Lumito AB (publ) ("Lumito" or the "Company") issued warrants of series TO6 in connection to an issue and loan financing during the fourth quarter of 2023. Each warrant gives the right to subscribe for one (1) new share in the Company. The subscription price for the warrants has been set to 70 percent of the […]